Human Diabetic Primary Kidney Vein Fibroblast Cells
BVXDF009
Certified
QualityGlobal
ShippingSupport
24/7Info
IncludedProduct Details
Size
1ml
Product Code
BVXDF009
Quick Specifications
- Product Type: Human Type II Diabetes Endothelial Cells
- Viability: >95% viable (Trypan Blue exclusion)
- Storage: Store in liquid nitrogen vapor phase (-196°C) for long-term. Ship on dry ice (-80°C).
- Shelf Life: Very stable in the Liquid Nitrogen Vapor Phase
- Catalog: BVXDF009
- Growth: Primary cells capable of multiple passages when using recommended medium and proper handling
Human Diabetic Primary Kidney Vein Fibroblast Cells
Product Description
Human Diabetic Primary Kidney Vein Fibroblast Cells are specialized cells derived from the kidney's venous tissue of individuals with diabetes. These fibroblasts play a crucial role in the kidney's structural integrity and function, as they contribute to the extracellular matrix and support the surrounding tissues. Guarantee expansion for a minimum of 2-5 population doublings. IMPORTANT: Quality warranty requires use of Bioverax media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.
Key Features & Benefits
Catalog Number: BVXDF009 Product Format: Frozen Vial Cell Number: > 5x10[5] cells/vial Passage:1(P1) Storage: Liquid Nitrogen, Vapor Phase Intended Use: Research use only (RUO) Cell Characteristics Primary Cells: These are isolated directly from human tissue (kidney vein) and have not been immortalized. They have a finite lifespan and closely mimic the in vivo physiological state. Diabetic Origin: The donor has a confirmed diagnosis of diabetes mellitus (often Type II). These cells retain the epigenetic and metabolic memory of the diabetic state (e.g., increased basal expression of inflammatory cytokines, altered glucose metabolism). Anatomical Location: The renal vein is the vessel that carries filtered blood away from the kidney. Fibroblasts from this site are crucial for studying vascular fibrosis and the structural changes in the kidney's vascular outflow tract under hyperglycemic conditions.
Quick Facts
Product Type
Human Type II Diabetes Endothelial Cells
Viability
>95% viable (Trypan Blue exclusion)
Storage
Store in liquid nitrogen vapor phase (-196°C) for long-term. Ship on dry ice (-80°C).
Shelf Life
Very stable in the Liquid Nitrogen Vapor Phase
Applications
Technical Specifications
| Product Type | Human Type II Diabetes Endothelial Cells |
|---|---|
| Viability | >95% viable (Trypan Blue exclusion) |
| Proliferative Capability | Primary cells capable of multiple passages when using recommended medium and proper handling |
| Storage Conditions | Store in liquid nitrogen vapor phase (-196°C) for long-term. Ship on dry ice (-80°C). |
| Shelf Life | Very stable in the Liquid Nitrogen Vapor Phase |
| Product Code | BVXDF009 |
| Size/Format | 1ml |
| Category | Primary Cells |
Primary Applications
Applications & Use Cases
Primary Applications
Diabetic Nephropathy: Investigating the mechanisms of renal fibrosis
Suitable for diabetic nephropathy: investigating the mechanisms of renal fibrosis studies and research applications
extracellular matrix (ECM) accumulation (Collagen I
Suitable for extracellular matrix (ecm) accumulation (collagen i studies and research applications
Fibronectin)
Suitable for fibronectin) studies and research applications
and the epithelial-mesenchymal transition (EMT) signaling pathways. Inflammation: Examining the role of hyperglycemia in activating NF-?B and releasing IL-6
Suitable for and the epithelial-mesenchymal transition (emt) signaling pathways. inflammation: examining the role of hyperglycemia in activating nf-?b and releasing il-6 studies and research applications
TNF-?
Suitable for tnf-? studies and research applications
and MCP-1. Drug Screening: Testing anti-fibrotic agents (e.g.
Suitable for and mcp-1. drug screening: testing anti-fibrotic agents (e.g. studies and research applications
SGLT2 inhibitors
Suitable for sglt2 inhibitors studies and research applications
GLP-1 analogs
Suitable for glp-1 analogs studies and research applications
or TGF-? inhibitors) in a cell type directly relevant to diabetic complications. Vascular Remodeling: Understanding how high glucose environments affect the structural integrity of the renal venous system.
Suitable for or tgf-? inhibitors) in a cell type directly relevant to diabetic complications. vascular remodeling: understanding how high glucose environments affect the structural integrity of the renal venous system. studies and research applications
Research Use Cases
In Vitro Studies
Cell culture and screening applications
Molecular Biology
Gene expression & signaling studies
Drug Discovery
Screening & validation studies
Technical Support & Documentation
Technical Support
Our experts are available for technical questions and protocol assistance.
Contact Support
